Compare

Semnur Pharmaceuticals, Inc. vs Accustem Sciences Inc. vs NeuroSense Therapeutics Ltd. vs Ocean Biomedical, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Semnur Pharmaceuticals, Inc. SMNR	Accustem Sciences Inc. ACUT	NeuroSense Therapeutics Ltd. NRSN	Ocean Biomedical, Inc. OCEALast annual report: year ended 2024-12-31
Year ended	2025-12-31	2025-12-31	2025-12-31	2024-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$160.42M	-$1.76M	-$11.12M	-$9.48M
EPS (Diluted)	-$0.78	-$0.12	-$0.44	-$0.34
Operating cash flow	-$5.87M	-$850.4K	-$7.67M	-$4.18M
Free cash flow	n/a	n/a	-$7.68M	n/a
Cash & equivalents	$20.0K	n/a	$166.0K	n/a
Total assets	$1.35M	$1.55M	$1.03M	$902.0K
Total liabilities	$22.10M	$4.95M	$2.59M	$98.52M
Shareholders' equity	-$20.75M	-$3.40M	-$1.56M	-$97.62M
Return on year-end equity	n/a	n/a	n/a	n/a
Shares outstanding	230.21M	16.07M	32.56M	34.87M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Semnur Pharmaceuticals, Inc.	Accustem Sciences Inc.	NeuroSense Therapeutics Ltd.	Ocean Biomedical, Inc.
Latest	n/a	n/a	n/a	n/a
1 year earlier	n/a	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a